CTX001
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

CTX001 Trademark

Serial Number: 97267617

CTX001 is a trademark filed by VERTEX PHARMACEUTICALS INCORPORATED on February 15, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

VERTEX PHARMACEUTICALS INCORPORATED (189 trademarks)

Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

February 15, 2022

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia

Providing health information to patients, caregivers and health care professionals; providing health care information relating to blood disorders, and information relating to the therapeutic properties of pharmaceuticals used for treating blood disorders

Providing medical and scientific research information in the field of blood disorders, and in the field of pharmaceuticals for treating blood disorders

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 7, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 7, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 7, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 15, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 15, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 15, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2022 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Apr 10, 2022 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 10, 2022 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2022 NWOS
NEW APPLICATION ENTERED
Feb 18, 2022 NWAP